PNEUMOCOCCAL BIOFILMS AND THEIR INTERVENTION STRATEGIES

  • Lovely Rahaman Microbial Ecology Lab, Department of Microbiology, Tripura University, Suryamaninagar, West Tripura, 799022
  • Sushanta Ghosh Microbial Ecology Lab, Department of Microbiology, Tripura University, Suryamaninagar, West Tripura, 799022
  • Nandita Nath Microbial Ecology Lab, Department of Microbiology, Tripura University, Suryamaninagar, West Tripura, 799022
  • Bipin Kumar Sharma Microbial Ecology Lab, Department of Microbiology, Tripura University, Suryamaninagar, West Tripura, 799022

Abstract

Pneumonia is a fatal infection with hard time breathing, cough, and fever. The children are at high risk worldwide due to pneumonia. This is responsible for childhood mortality and morbidity worldwide. It is mainly caused by bacteria. Pneumonia-causing bacteria are resistant to most of the antibiotics and therapeutic agents due to the formation of biofilms. Laboratories around the world are trying to develop strategies to combat pneumococcal biofilms. This review deals with the formation of pneumococcal biofilms and their different intervention strategies. 

Keywords: Pneumonia, Biofilms, Streptococcus pneumoniae, Intervention Strategies

Downloads

Download data is not yet available.

References

1. www.who.int/mediacentre/factsheets/fs331/en/(WHO Fact sheets Nov 2013); 2013.
2. Nadell CD, Xavier JB, Levin SA, Foster KR. The evolution of quorum sensing in bacterial biofilms. PLoS Biol 2008;6:14.
3. Johnson LR. Microcolony and biofilm formation as a survival strategy for bacteria. J Theor Biol 2008;251:24-34.
4. Hall Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2:95-108.
5. Kerksiek K. A life in slime biofilms rules the world. Infection Res News Perspectives 2008;9:1571–8.
6. Jabra Rizk MA, Meiller TF, James CE, Shirtliff ME. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother 2006;50:1463-9.
7. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003;112:1466-77.
8. Lawrence JR, Swerhone GD, Kuhlicke U, Neu TR. In situ evidence for microdomains in the polymer matrix of bacterial micro colonies. Can J Microbiol 2007;53:450-8.
9. Moscosco M, Garcia E, Lopez R. Pneumococcal biofilms-review article. Int Microbiol 2009;12:77-85.
10. Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, Sauer K. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol 2006;188:2325.
11. Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, Ricci S, et al. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 2006;61:1196-10.
12. Moscosco M, García E, Lopez R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 2006;188:7785.
13. Munoz-Elias EJ, Marcano, Camilli A. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infec Immun 2008;76:5049-61.
14. Cvitkovitch DG, Li YH, Ellen RP. Quorum sensing and biofilm formation in streptococcal infections. J Clin Invest 2003;112:1626-32.
15. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med 2008;59:415-28.
16. WHO/CDS/CSR/EPH/2002.12; 2002.
17. McCullers JA, Karlström A, Iverson AR, Loeffler JM, Fischetti VA. Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathog 2007;3:e28.
18. Lu TK, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA 2007; 104:11197-202.
19. Davies DG, Marques NH. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 2009;191:1393-403.
20. Moscoso M, Claverys JP. Release of DNA into the medium by competent Streptococcus pneumoniae: kinetics, mechanism and stability of the liberated DNA. Mol Microbiol 2004;54:783-94.
21. Schaudinn C, Stoodley P, Kainovic A. Bacterial biofilms, other structures seen as mainstream concepts. Microbe 2007;2:231-7.
22. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004;430:242-9.
23. Susana P, Jesus RL, Juan BL. Review of probiotics for use in bivalve hatcheries. Vet Microbiol 2010;145:187-97.
24. Castillo G, Morosini MI, Valverde A. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother 2007;59:301–4.
25. Marks LR, Parameswaran GI, Hakansson AP. Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. Infec Immun 2012;80:2744–60.
26. Yadav MK, Park SW, Chae SW, Song JJ. Sinefungin, a natural nucleoside analogue of S-Adenosyl methionine, inhibits Streptococcus pneumoniae biofilm growth. Biomed Res Int 2014:1–10. http://dx.doi.org/10.1155/2014/156987
27. Yadav MK, Go YY, Chae SW, Song JJ. The small molecule dam inhibitor, pyrimidinedione, disrupts Streptococcus pneumoniae biofilm growth in vitro. PLoS One 2015;10:e0139238.
28. Pasteur AR, Sasha D, Paul M. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis. Int J Antimicrob Agents 2015;46:242-8.
29. Burghout P, Vullo D, Scozzafava A, Hermans WM, Supuran CT. Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: towards innovative drug design of antiinfectives. Bioorg Med Chem 2011;19:243–8.
30. Franzetti A, Bestetti G, Caredda P, LaColla P, Tamburini E. Surface-active compounds and their role in the access to hydrocarbons in Gordonia strains. FEMS Microbiol Ecol 2008;63:238-48.
31. Pradhan AK, Pradhan N, Mall G, Panda HT, Sukla LB, Panda PK, et al. Application of lipopeptide biosurfactant isolated from a halophile: Bacillus tequilensis CH for inhibition of biofilm. Appl Biochem Biotechnol 2013;171:1362-75.
32. Rodrigues L, Van der Mei HC, Teixeira J, Oliveira R. Influence of biosurfactants from probiotic bacteria on formation of biofilms on voice prostheses. Appl Environ Microbiol 2004;70:4408-10.
33. Rufino RD, Luna JM, Sarubbo LA, Rodrigues LR, Teixeira JA, Campos-Takaki GM. Antimicrobial and anti-adhesive potential of a biosurfactant Rufisan produced by Candida lipolytica UCP 0988. Colloids Surf B 2011;84:1–5.
34. Bibbs RK, Harris RD, Peoples VA, Barnett C, Singh SR, Dennis VA, et al. Silver polyvinyl pyrrolidone nano particles exhibit a capsular polysaccha-ride influenced bactericidal effect against Streptococcus pneumoniae. Front Microbiol 2014;5:665.
35. Wilson A, Prabukumar S, Sathishkumar G, Sivaramakrishnan S. Aspergillus flavus mediated silver nanoparticles synthesis and evaluation of ITS antimicrobial activity against different human pathogens. Int J Appl Pharm 2016;8:43-6.
36. Grienke U, Richter M, Walther E, Hoffmann A, Kirchmair J, Makarov V, et al. Discovery of prenylated flavonoids with dual activity against Influenza virus and Streptococcus pneumoniae. Sci Rep 2016;6:27156.
37. Mutalib LY, Nuraddin SM, Aka ST. Phytochemical screening, antibacterial and antibiofilm evaluation of Lagenaria siceraria fruit growing in Kurdistan Region\Iraq. J Pharmacogn Phytochem 2015;4:45-9.
38. Minami M, Konishi T, Takase H, Makino T. Shin’iseihaito (Xinyiqingfeitang) Suppresses the biofilm formation of Streptococcus pneumoniae in vitro. BioMed Res Int 2017. https://doi.org/10.1155/2017/4575709.
39. Talekar SJ, Chochua S, Nelson K, Klugman KP, Quave CL, Vidal JE. 220D-F2 from Rubus ulmifolius Kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms. PLoS One 2014; 9:e97314.
40. Kaplan JB, LoVetri K, Cardona ST, Madhyastha S, Sadovskay I, Jabbouri S, et al. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in Staphylococci. J Antibiot 2012;65:73–7.
41. Manimekalai K, Srinivasan P, Dineshbabu J, Guna G, Teepica Priya Darsini D. Anti-biofilm efficacy of Plectranthus amboinicus against Streptococcus pyogenes isolated from pharyngitis patients. Asian J Pharm Clin Res 2016;9:348-54.
42. Dineshbabu J, Srinivasan P, Manimekalai K, Teepica Priya Darsini D. In vitro antibiofilm activity of Gymnema sylvestre extract against biofilm forming Streptococcus pyogenes from upper respiratory tract. Asian J Pharm Clin Res 2016;9:83-6.
Statistics
315 Views | 784 Downloads
Citatons
How to Cite
Rahaman, L., S. Ghosh, N. Nath, and B. K. Sharma. “PNEUMOCOCCAL BIOFILMS AND THEIR INTERVENTION STRATEGIES”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 10, no. 3, Mar. 2018, pp. 5-8, doi:10.22159/ijpps.2018v10i3.23254.
Section
Review Article(s)